[1]
|
Uysal, H.A., Tiftikcioğlu, B.I., Öcek, L., et al. (2019) Serum Levels of Melatonin and Sleep Evaluation Scales in the Di-agnosis of Sleep Disorders in Patients with Idiopathic Parkinson’s Disease. Noro Psikiyatri Arsivi, 56, 264-268.
|
[2]
|
Djeridane, Y., Vivien-Roels, B., Simonneaux, V., et al. (1998) Evidence for Melatonin Synthesis in Ro-dent Harderian Gland: A Dynamic in Vitro Study. Journal of Pineal Research, 25, 54-64.
https://doi.org/10.1111/j.1600-079X.1998.tb00386.x
|
[3]
|
Reiter, R.J., Tan, D.X., Kim, S.J., et al. (2014) Delivery of Pineal Melatonin to the Brain and SCN: Role of Canaliculi, Cerebrospinal Fluid, Tanycytes and Virchow-Robin Peri-vascular Spaces. Brain Structure and Function, 219, 1873- 1887. https://doi.org/10.1007/s00429-014-0719-7
|
[4]
|
Bloem, B.R., Okun, M.S. and Klein, C. (2021) Parkinson’s Dis-ease. The Lancet, 397, 2284-2303.
https://doi.org/10.1016/S0140-6736(21)00218-X
|
[5]
|
Pan, P.Y. and Yue, Z. (2014) Genetic Causes of Parkin-son’s Disease and Their Links to Autophagy Regulation. Parkinsonism & Related Disorders, 20, S154-S157. https://doi.org/10.1016/S1353-8020(13)70037-3
|
[6]
|
Virameteekul, S,, Phokaewvarangkul, O. and Bhidayasiri, R. (2021) Profiling the Most Elderly Parkinson’s Disease Patients: Does Age or Disease Duration Matter? PLOS ONE, 16, e0261302.
https://doi.org/10.1371/journal.pone.0261302
|
[7]
|
Shukla, P., Rao, G.M., Pandey, G., et al. (2014) Therapeutic Interventions in Sepsis: Current and Anticipated Pharmacological Agents. British Journal of Pharmacology, 171, 5011-5031. https://doi.org/10.1111/bph.12829
|
[8]
|
Mukoyama, M., Nakao, K., Saito, Y., et al. (1990) Human Brain Natriuretic Peptide, a Novel Cardiac Hormone. The Lancet, 335, 801-802. https://doi.org/10.1016/0140-6736(90)90925-U
|
[9]
|
Bjorklund, G., Stejskal, V., Urbina, M.A., et al. (2018) Met-als and Parkinson’s Disease: Mechanisms and Biochemical Processes. Current Medicinal Chemistry, 25, 2198-2214. https://doi.org/10.2174/0929867325666171129124616
|
[10]
|
Marras, C., Canning, C.G. and Goldman, S.M. (2019) Environment, Lifestyle, and Parkinson’s Disease: Implications for Prevention in the Next Decade. Movement Disorders, 34, 801-811. https://doi.org/10.1002/mds.27720
|
[11]
|
Deng, H., Wang, P. and Jankovic, J. (2018) The Genetics of Parkinson Disease. Ageing Research Reviews, 42, 72-85.
https://doi.org/10.1016/j.arr.2017.12.007
|
[12]
|
Cherian, A. and Divya, K.P. (2020) Genetics of Parkinson’s Dis-ease. Acta Neurologica Belgica, 120, 1297-1305.
https://doi.org/10.1007/s13760-020-01473-5
|
[13]
|
Riboldi, G.M. and Di Fonzo, A.B. (2019) GBA, Gaucher Dis-ease, and Parkinson’s Disease: From Genetic to Clinic to New Therapeutic Approaches. Cells, 8, 364. https://doi.org/10.3390/cells8040364
|
[14]
|
Simon, D.K., Tanner, C.M. and Brundin, P. (2020) Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology. Clinics in Geriatric Medicine, 36, 1-12. https://doi.org/10.1016/j.cger.2019.08.002
|
[15]
|
Liu, M., Luo, Y.J., Gu, H.Y., et al. (2021) Sex and On-set-Age-Related Features of Excessive Daytime Sleepiness and Night-Time Sleep in Patients with Parkinson’s Disease. BMC Neurology, 21, Article No. 165.
https://doi.org/10.1186/s12883-021-02192-x
|
[16]
|
Iijima, M., Osawa, M., Yasuda, S., et al. (2021) Association between Excessive Daytime Sleepiness and the Cholinergic Ascending Reticular System in Parkinson’s Disease. Neuro-degenerative Diseases, 21, 48-54.
https://doi.org/10.1159/000519776
|
[17]
|
Feng, F., Cai, Y., Hou, Y., et al. (2021) Excessive Daytime Sleepiness in Parkinson’s Disease: A Systematic Review and Meta-Analysis. Parkinsonism & Related Disorders, 85, 133-140. https://doi.org/10.1016/j.parkreldis.2021.02.016
|
[18]
|
Knie, B., Mitra, M.T., Logishetty, K., et al. (2011) Excessive Daytime Sleepiness in Patients with Parkinson’s Disease. CNS Drugs, 25, 203-212. https://doi.org/10.2165/11539720-000000000-00000
|
[19]
|
Gallazzi, M., Mauri, M., Bianchi, M.L., et al. (2021) Selegiline Reduces Daytime Sleepiness in Patients with Parkinson’s Disease. Brain and Behavior, 11, e01880. https://doi.org/10.1002/brb3.1880
|
[20]
|
Hu, M.T. (2020) REM Sleep Behavior Disorder (RBD). Neurobiology of Disease, 143, Article ID: 104996.
https://doi.org/10.1016/j.nbd.2020.104996
|
[21]
|
Xie, C., Zhu, M. and Hu, Y. (2021) Risk Stratification for REM Sleep Behavior Disorder in Patients with Parkinson’s Disease: A PRISMA-Compliant Meta-Analysis and Systematic Review. Clinical Neurology and Neurosurgery, 202, Article ID: 106484. https://doi.org/10.1016/j.clineuro.2021.106484
|
[22]
|
Jiang, H., Huang, J., Shen, Y., et al. (2017) RBD and Neuro-degenerative Diseases. Molecular Neurobiology, 54, 2997- 3006. https://doi.org/10.1007/s12035-016-9831-4
|
[23]
|
Jozwiak, N., Postuma, R.B., Montplaisir, J., et al. (2017) REM Sleep Behavior Disorder and Cognitive Impairment in Parkinson’s Disease. Sleep, 40, zsx101. https://doi.org/10.1093/sleep/zsx101
|
[24]
|
Shin, C., Park, H., Lee, W.W., et al. (2019) Clonazepam for Probable REM Sleep Behavior Disorder in Parkinson’s Disease: A Randomized Placebo-Controlled Trial. Journal of the Neuro-logical Sciences, 401, 81-86.
https://doi.org/10.1016/j.jns.2019.04.029
|
[25]
|
Yang, X., Liu, B., Shen, H., et al. (2018) Prevalence of Restless Legs Syndrome in Parkinson’s Disease: A Systematic Review and Meta-Analysis of Observational Studies. Sleep Medi-cine, 43, 40-46.
https://doi.org/10.1016/j.sleep.2017.11.1146
|
[26]
|
Marques, A., Figorilli, M., Lambert, C., et al. (2021) The Urge to Move: From Restless Legs Syndrome to Impulse Control Disorders in Parkinson’s Disease. Journal of Sleep Research, 30, e13127. https://doi.org/10.1111/jsr.13127
|
[27]
|
De Rosa, A., Guacci, A., Peluso, S., et al. (2013) A Case of Restless Leg Syndrome in a Family with LRRK2 Gene Mutation. International Journal of Neuroscience, 123, 283-285. https://doi.org/10.3109/00207454.2012.756485
|
[28]
|
Piao, Y.S., Lian, T.H., Hu, Y., et al. (2017) Restless Legs Syndrome in Parkinson Disease: Clinical Characteristics, Abnormal Iron Metabolism and Altered Neurotransmitters. Scientific Reports, 7, Article No. 10547.
https://doi.org/10.1038/s41598-017-10593-7
|
[29]
|
Sobreira-Neto, M.A., Pena-Pereira, M.A., Sobreira, E.S.T., et al. (2021) Is Restless Legs Syndrome in Parkinson Disease Patients Associated with Any Specific Factor? Arquivos de Neuro-Psiquiatria, 79, 38-43.
https://doi.org/10.1590/0004-282x-anp-2020-0122
|
[30]
|
Esposito, E. and Cuzzocrea, S. (2010) Antiinflammatory Activity of Melatonin in Central Nervous System. Current Neuropharmacology, 8, 228-242. https://doi.org/10.2174/157015910792246155
|
[31]
|
Cardinali, D.P., Golombek, D.A., Rosenstein, R.E., et al. (1997) Melatonin Site and Mechanism of Action: Single or Multiple? Journal of Pineal Research, 23, 32-39. https://doi.org/10.1111/j.1600-079X.1997.tb00332.x
|
[32]
|
Leclerc, V., Ettaoussi, M., Rami, M., et al. (2011) De-sign and Synthesis of Naphthalenic Derivatives as New Ligands at the Melatonin Binding Site MT3. European Journal of Medicinal Chemistry, 46, 1622-1629.
https://doi.org/10.1016/j.ejmech.2011.02.010
|
[33]
|
Tan, D.X., Reiter, R.J., Manchester, L.C., et al. (2002) Chemical and Physical Properties and Potential Mechanisms: Melatonin as a Broad Spectrum Antioxidant and Free Radical Scav-enger. Current Topics in Medicinal Chemistry, 2, 181-197. https://doi.org/10.2174/1568026023394443
|
[34]
|
Reiter, R.J., Mayo, J.C., Tan, D.X., et al. (2016) Melatonin as an Antioxidant: Under Promises But over Delivers. Journal of Pineal Research, 61, 253-278. https://doi.org/10.1111/jpi.12360
|
[35]
|
Cui, L., Xu, F., Jiang, Z., et al. (2021) Mela-tonin Regulates Proliferation and Apoptosis of Endometrial Stromal Cells via MT1. Acta Biochimica et Biophysica Sinica (Shanghai), 53, 1333-1341. https://doi.org/10.1093/abbs/gmab108
|
[36]
|
Feng, T.Y., Li, Q., Ren, F., et al. (2020) Melatonin Protects Goat Spermatogonial Stem Cells against Oxidative Damage during Cryopreservation by Improving Antioxidant Capacity and Inhibiting Mitochondrial Apoptosis Pathway. Oxidative Medicine and Cellular Longevity, 2020, Article ID: 5954635. https://doi.org/10.1155/2020/5954635
|
[37]
|
Tamtaji, O.R., Reiter, R.J., Alipoor, R., et al. (2020) Melatonin and Parkinson Disease: Current Status and Future Perspectives for Molecular Mechanisms. Cell Molecular Neurobiology, 40, 15-23.
https://doi.org/10.1007/s10571-019-00720-5
|
[38]
|
Niranjan, R., Nath, C. and Shukla, R. (2010) The Mechanism of Action of MPTP-Induced Neuroinflammation and Its Modulation by Melatonin in Rat Astrocytoma Cells, C6. Free Rad-ical Research, 44, 1304-1316.
https://doi.org/10.3109/10715762.2010.501080
|
[39]
|
Hardeland, R. (2018) Melatonin and Inflammation-Story of a Double-Edged Blade. Journal of Pineal Research, 65, e12525. https://doi.org/10.1111/jpi.12525
|
[40]
|
Bilici, D., Akpinar, E. and Kiziltunç, A. (2002) Protective Effect of Melatonin in Carrageenan-Induced Acute Local Inflammation. Pharmacological Research, 46, 133-139. https://doi.org/10.1016/S1043-6618(02)00089-0
|
[41]
|
Tholfsen, L.K., Larsen, J.P., Schulz, J., et al. (2015) Development of Excessive Daytime Sleepiness in Early Parkinson Disease. Neu-rology, 85, 162-168. https://doi.org/10.1212/WNL.0000000000001737
|
[42]
|
Videnovic, A., Noble, C., Reid, K.J., et al. (2014) Circadian Melatonin Rhythm and Excessive Daytime Sleepiness in Parkinson Disease. JAMA Neurology, 71, 463-469. https://doi.org/10.1001/jamaneurol.2013.6239
|
[43]
|
Vecchierini, M.F., Kilic-Huck, U. and Quera-Salva, M.A. (2021) Melatonin (MEL) and Its Use in Neurological Diseases and Insomnia: Recommendations of the French Medical and Research Sleep Society (SFRMS). Revue Neurologique (Paris), 177, 245-259. https://doi.org/10.1016/j.neurol.2020.06.009
|
[44]
|
Boeve, B.F., Silber, M.H. and Ferman, T.J. (2003) Melatonin for Treatment of REM Sleep Behavior Disorder in Neurologic Disorders: Results in 14 Patients. Sleep Medicine, 4, 281-284. https://doi.org/10.1016/S1389-9457(03)00072-8
|